financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Keeps Hold Opinion On Shares Of Inspire Medical Systems, Inc.
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Keeps Hold Opinion On Shares Of Inspire Medical Systems, Inc.
Jun 11, 2024 8:46 AM

11:15 AM EDT, 06/11/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We cut our 12-month price target to $175 from $225 due to recent market movements, based on a forward P/E of 233x our 2025 EPS estimate of $0.75, a discount to INSP's historical forward average due to decelerating growth versus historical. We maintain our adjusted EPS estimate of $0.15 for 2024 and $0.75 for 2025. We still view the balance sheet favorably with good liquidity (i.e., a high current ratio of 7.9x) and solvency (i.e., total debt/capital low at just 4%). We see the company adding new centers ahead of its targets, which should bring additional top-line growth over the next one to two years. We also anticipate growth from the next-generation Inspire V soft launch later this year and the full launch next year.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Keeps Buy Opinion On Shares Of American International Group
Research Alert: CFRA Keeps Buy Opinion On Shares Of American International Group
Nov 10, 2025
08:10 AM EST, 11/10/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We keep our 12-month target price of $90, valuing AIG shares at 10.3x our newly initiated 2027 operating EPS estimate of $8.70 and at 11.5x our 2026 EPS estimate of...
Research Alert: CFRA Keeps Hold Opinion On Shares Of Solventum Corporation
Research Alert: CFRA Keeps Hold Opinion On Shares Of Solventum Corporation
Nov 10, 2025
10:50 AM EST, 11/10/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We cut our 12-month price target by $3 to $75 using a forward P/E of 12x our 2026 EPS view of $6.29 (raised by $0.16), in line with historical averages....
Research Alert: CFRA Maintains Buy Opinion On Shares Of Super Micro Computer, Inc.
Research Alert: CFRA Maintains Buy Opinion On Shares Of Super Micro Computer, Inc.
Nov 10, 2025
11:30 AM EST, 11/10/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We cut our 12-month target price to $49 from $57, shifting to 15x our CY 27 EPS view of $3.27, below SMCI's three-year historical average, reflecting heightened near-term volatility and...
Research Alert: CFRA Maintains Strong Buy Opinion On Shares Of Royal Gold Inc.
Research Alert: CFRA Maintains Strong Buy Opinion On Shares Of Royal Gold Inc.
Nov 10, 2025
10:45 AM EST, 11/10/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We increase our 12-month target price by $17 to $248, or 24.0x our 2026 EPS estimate, a discount to RGLD's two-year average forward P/E of 25.2x and a larger discount...
Copyright 2023-2026 - www.financetom.com All Rights Reserved